Login to Your Account

Bench Press: BioWorld looks at translational medicine

Monday, December 16, 2013
Researchers at Memorial Sloan-Kettering Cancer Center have synthesized the hormone erythropoietin (EPO), which controls blood synthesis and is used in recombinant form for the treatment of anemia and myelodysplasia, via completely chemical means.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription